Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not?

by Dimitrios Patoulias, MD, Aristi Boulmpou, MD, Christodoulos E. Papadopoulos, PhD, Michael Doumas, PhD
Published 2021-07-01

Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design

by Aristi Boulmpou, Anastasios Kartas, Ioannis Farmakis, Stefanos Zafeiropoulos, Vasileios Nevras, Ioannis Papadimitriou, Athina Tampaki, Anastasia Vlachou, Leonidas Lillis, Athanasios Koutsakis, Haralampos Karvounis, George Giannakoulas
Published 2019-07-01